Bronnen:
- Cohen SB, Tanaka Y, Mariette X, et al. Long-term safety of tofacitinib for the treatment of rheumatoid arthritis up to 8.5 years: integrated analysis of data from the global clinical trials. Ann Rheum Dis. 2017;76:1253-62.
Bronnen:
jan 2022 | Osteoporose
dec 2021 | Osteoporose
sep 2021 | Osteoporose
sep 2021 | Osteoporose
aug 2021 | Osteoporose
jul 2021 | Eczeem, Huidinfecties, Psoriasis
dec 2020 | Osteoporose
dec 2020 | Osteoporose
nov 2020